Screener
Agios Pharmaceuticals AGIO Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
| (In thousands, except share and per share data) | June 30,2026 | December 31,2025 |
|---|---|---|
| Total liabilities | 82,403 | 104,111 |
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value; 125,000,000 shares authorized; 75,821,241 shares issued and 59,604,830 outstanding at June 30, 2026, and 74,665,003 shares issued and 58,448,592 outstanding at December 31, 2025 | 76 | 75 |
| Additional paid-in capital | 2,591,745 | 2,555,037 |
| Accumulated other comprehensive (loss) income | (1,795) | 2,193 |
| Accumulated deficit | (761,519) | (561,705) |
| Treasury stock, at cost (16,216,411 shares at June 30, 2026 and December 31, 2025) | (802,486) | (802,486) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Agios Pharmaceuticals's common stock, par value (in dollars per share)?
- Agios Pharmaceuticals (AGIO) reported common stock, par value (in dollars per share) of $0 in Q2 2026.
- How has Agios Pharmaceuticals's common stock, par value (in dollars per share) changed year-over-year?
- Agios Pharmaceuticals's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Agios Pharmaceuticals's common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.
Ask your AI about Agios Pharmaceuticals's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude